MTORC1 phosphorylates LARP6 to stimulate type i collagen expression

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Zhang, Yujie ^a   Stefanovic, Branko ^a  

^a FLORIDA STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; COLLAGEN TYPE 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MESSENGER RNA; RAPAMYCIN; RIBONUCLEOPROTEIN; SS-B ANTIGEN; STRAP PROTEIN, HUMAN; TUMOR PROTEIN;

FIBROBLAST; HEK293 CELL LINE; HUMAN; METABOLISM; PHOSPHORYLATION; SECRETION (PROCESS);

AUTOANTIGENS; COLLAGEN TYPE I; FIBROBLASTS; HEK293 CELLS; HUMANS; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; NEOPLASM PROTEINS; PHOSPHORYLATION; RIBONUCLEOPROTEINS; RNA, MESSENGER; SIROLIMUS;

EID: 85010310968     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep41173     Document Type: Article

References (64)

1. Kivirikko, K. I. Collagen biosynthesis: a mini-review cluster. Matrix Biol. 16, 355-356 (1998).
2. Smith, K., Rennie, M. J. New approaches and recent results concerning human-tissue collagen synthesis. Curr. Opin. Clin. Nutr. Metab. Care 10, 582-590 (2007).
3. Rockey, D. C., Bell, P. D., Hill, J. A. Fibrosis-A Common Pathway to Organ Injury and Failure. N. Engl. J. Med. 372, 1138-1149 (2015).
4. Lindquist, J. N., Marzluff, W. F., Stefanovic, B. III. Posttranscriptional regulation of type I collagen. Am. J. Physiol. Gastrointest. Liver Physiol. 279, G471-G476 (2000).
5. Lindquist, J. N., Stefanovic, B., Brenner, D. A. Regulation of collagen alpha1 (I) expression in hepatic stellate cells. J. Gastroenterol. 35, 80-83 (1999).
6. Stefanovic, B., et al. Posttranscriptional regulation of collagen alpha1(I) mRNA in hepatic stellate cells. Mol. Cell. Biol. 17, 5201-5209 (1997).
7. Tsukada, S., Parsons, C. J., Rippe, R. A. Mechanisms of liver fibrosis. Clin. Chim. Acta 364, 33-60 (2006).
8. Wang, H., Stefanovic, B. Role of LARP6 and Nonmuscle Myosin in Partitioning of Collagen mRNAs to the ER Membrane. PLOS ONE 9, e108870 (2014).
9. Challa, A. A., Stefanovic, B. A Novel Role of Vimentin Filaments: Binding and Stabilization of Collagen mRNAs. Mol. Cell. Biol. 31, 3773-3789 (2011).
10. Stefanovic, L., Longo, L., Zhang, Y., Stefanovic, B. Characterization of binding of LARP6 to the 5 stem-loop of collagen mRNAs: Implications for synthesis of type I collagen. RNA Biol. 11, 1386-1401 (2014).
11. Cai, L., Fritz, D., Stefanovic, L., Stefanovic, B. Binding of LARP6 to the conserved 5 stem-loop regulates translation of mRNAs encoding type I collagen. J. Mol. Biol. 395, 309-326 (2010).
12. Cai, L., Fritz, D., Stefanovic, L., Stefanovic, B. Nonmuscle myosin-dependent synthesis of type I collagen. J. Mol. Biol. 401, 564-578 (2010).
13. Manojlovic, Z., Stefanovic, B. A novel role of RNA helicase A in regulation of translation of type I collagen mRNAs. RNA 18, 321-334 (2012).
14. Vukmirovic, M., Manojlovic, Z., Stefanovic, B. Serine-Threonine Kinase Receptor-Associated Protein (STRAP) Regulates Translation of Type I Collagen mRNAs. Mol. Cell. Biol. 33, 3893-3906 (2013).
15. Hara, K., et al. Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action. Cell 110, 177-189 (2002).
16. Kim, D., et al. mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery. Cell 110, 163-175 (2002).
17. Loewith, R., et al. Two TOR Complexes, Only One of which Is Rapamycin Sensitive, Have Distinct Roles in Cell Growth Control. Mol. Cell 10, 457-468 (2002).
18. Jacinto, E., et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 6, 1122-1128 (2004).
19. Dos, D. S., et al. Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton. Curr. Biol. 14, 1296-1302 (2004).
20. Hresko, R. C., Mueckler, M. mTOR RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J. Biol. Chem. 280, 40406-40416 (2005).
21. Sarbassov, D. D., Guertin, D. A., Ali, S. M., Sabatini, D. M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101 (2005).
22. Burnett, P. E., Barrow, R. K., Cohen, N. A., Snyder, S. H., Sabatini, D. M. RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc. Natl. Acad. Sci. USA 95, 1432-1437 (1998).
23. Brown, E. J., et al. Control of p70 S6 kinase by kinase activity of FRAP in vivo. Nature 377, 441 (1995).
24. Hara, K., et al. Regulation of eIF-4E BP1 phosphorylation by mTOR. J. Biol. Chem. 272, 26457-26463 (1997).
25. Martel, R., Klicius, J., Galet, S. Inhibition of the immune response by rapamycin, a new antifungal antibiotic. Can. J. Physiol. Pharmacol. 55, 48-51 (1977).
26. Calne, R., et al. Rapamycin for immunosuppression in organ allografting. Lancet 334, 227 (1989).
27. Zhu, J., et al. Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis. Gastroenterology 117, 1198-1204 (1999).
28. Bridle, K. R., et al. Rapamycin inhibits hepatic fibrosis in rats by attenuating multiple profibrogenic pathways. Liver Transpl. 15, 1315-1324 (2009).
29. Wu, M., et al. Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis. Kidney Int. 69, 2029-2036 (2006).
30. Korfhagen, T. R., et al. Rapamycin prevents transforming growth factor-induced pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 41, 562-572 (2009).
31. Zhang, Y., Stefanovic, B. Akt mediated phosphorylation of LARP6; critical step in biosynthesis of type I collagen. Sci. Rep. 6 (2016).
32. Hsu, P. P., et al. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332, 1317-1322 (2011).
33. Thoreen, C. C., et al. An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J. Biol. Chem. 284, 8023-8032 (2009).
34. Lamand S. R., et al. Endoplasmic reticulum-mediated quality control of type I collagen production by cells from osteogenesis imperfecta patients with mutations in the pro 1 (I) chain carboxyl-terminal propeptide which impair subunit assembly. J. Biol. Chem. 270, 8642-8649 (1995).
35. Tajima, S., Takehana, M., Azuma, N. Production of overmodified type I procollagen in a case of osteogenesis imperfecta. J. Dermatol. 21, 219-222 (1994).
36. Bateman, J. F., Mascara, T., Chan, D., Cole, W. G. Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfecta. Biochem. J 217, 103-115 (1984).
37. Bateman, J. F., Mascara, T., Chan, D., Cole, W. G. A structural mutation of the collagen alpha 1 (I) CB7 peptide in lethal perinatal osteogenesis imperfecta. J. Biol. Chem. 262, 4445-4451 (1987).
38. Schalm, S. S., Blenis, J. Identification of a conserved motif required for mTOR signaling. Curr. Biol. 12, 632-639 (2002).
39. Schalm, S. S., Fingar, D. C., Sabatini, D. M., Blenis, J. TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function. Curr. Biol. 13, 797-806 (2003).
40. Friedman, S. Hepatic stellate cells. Prog. Liver Dis. 14, 101-130 (1995).
41. De Minicis, S., et al. Gene expression profiles during hepatic stellate cell activation in culture and in vivo. Gastroenterology 132, 1937-1946 (2007).
42. Jiang, F., Parsons, C. J., Stefanovic, B. Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation. J. Hepatol. 45, 401-409 (2006).
43. Bergeron, J. J., Brenner, M. B., Thomas, D. Y., Williams, D. B. Calnexin: a membrane-bound chaperone of the endoplasmic reticulum. Trends Biochem. Sci. 19, 124-128 (1994).
44. Wada, I., et al. SSR alpha and associated calnexin are major calcium binding proteins of the endoplasmic reticulum membrane. J. Biol. Chem. 266, 19599-19610 (1991).
45. Drenan, R. M., Liu, X., Bertram, P. G., Zheng, X. F. S. FKBP12-Rapamycin-associated Protein or Mammalian Target of Rapamycin (FRAP/mTOR) Localization in the Endoplasmic Reticulum and the Golgi Apparatus. J. Biol. Chem. 279, 772-778 (2004).
46. Yadav, R. B., et al. mTOR direct interactions with Rheb-GTPase and raptor: sub-cellular localization using fluorescence lifetime imaging. BMC Cell Biol. 14, 1-16 (2013).
47. Becker, T., et al. Structure of monomeric yeast and mammalian Sec61 complexes interacting with the translating ribosome. Science 326, 1369-1373 (2009).
48. Dejgaard, K., et al. Organization of the Sec61 translocon, studied by high resolution native electrophoresis. J. Proteome Res. 9, 1763-1771 (2010).
49. Gogala, M., et al. Structures of the Sec61 complex engaged in nascent peptide translocation or membrane insertion. Nature 506, 107-110 (2014).
50. Lamande, S. R., Bateman, J. F. Procollagen folding and assembly: the role of endoplasmic reticulum enzymes and molecular chaperones. in Semin. Cell Dev. Biol. Vol. 10, 455-464 (Elsevier, 1999).
51. de Obanos, M. P. P., Zabalza, M. J. L., Prieto, J., Herraiz, M. T., Iraburu, M. J. Leucine stimulates procollagen 1 (I) translation on hepatic stellate cells through ERK and PI3K/Akt/mTOR activation. J. Cell. Physiol. 209, 580-586 (2006).
52. Neef, M., Ledermann, M., Saegesser, H., Schneider, V., Reichen, J. Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis. J. Hepatol. 45, 786-796 (2006).
53. Brass, A., Kadler, K., Thomas, J., Grant, M., Boot-Handford, R. The aromatic zipper: a model for the initial trimerization event in collagen folding. Biochem. Soc. Trans. 19, 365S (1991).
54. Khoshnoodi, J., Cartailler, J.-P., Alvares, K., Veis, A., Hudson, B. G. Molecular recognition in the assembly of collagens: terminal noncollagenous domains are key recognition modules in the formation of triple helical protomers. J. Biol. Chem. 281, 38117-38121 (2006).
55. Yoshizaki, A., et al. Treatment with rapamycin prevents fibrosis in tightskin and bleomycininduced mouse models of systemic sclerosis. Arthritis Rheum. 62, 2476-2487 (2010).
56. Yu, S.-Y., Liu, L., Li, P., Li, J. Rapamycin inhibits the mTOR/p70S6K pathway and attenuates cardiac fibrosis in adriamycin-induced dilated cardiomyopathy. J. Thorac. Cardiovasc. Surg. 61, 223-228 (2013).
57. Poulalhon, N., et al. Modulation of Collagen and MMP-1 Gene Expression in Fibroblasts by the Immunosuppressive Drug Rapamycin a Direct Role as an Antifibrotic Agent J. Biol. Chem. 281, 33045-33052 (2006).
58. He, T.-C., et al. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95, 2509-2514 (1998).
59. Graham, F., Smiley, J., Russell, W., Nairn, R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59-72 (1977).
60. DuBridge, R. B., et al. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7, 379-387 (1987).
61. Stewart, S. A., et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9, 493-501 (2003).
62. Weiskirchen, R., Gressner, A. M. Isolation and culture of hepatic stellate cells. In Fibrosis Research 99-113 (Springer, 2005).
63. Stephens, S. B., Dodd, R. D., Lerner, R. S., Pyhtila, B. M., Nicchitta, C. V. Analysis of mRNA partitioning between the cytosol and endoplasmic reticulum compartments of mammalian cells. In Post-Transcriptional Gene Regulation 197-214 (Springer, 2008).
64. Boguth, G., Harder, A., Scheibe, B., Wildgruber, R., Weiss, W. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21, 1037-1053 (2000).